Protein Expression Market

Protein Expression Market to
Reach $3 billion by 2023
[email protected]
Protein Expression Market
The protein expression market is expected to grow at a CAGR of 11.7% during 2017 2023, according to new market research report published by P&S Market Research.
Browse Report Summary with Detailed TOC on “Protein Expression Market by System
(Prokaryotic Expression Systems, Mammalian Cell Expression Systems, Insect Cell
Expression Systems, Yeast Expression Systems, Cell-Free Expression Systems, AlgalBased Expression Systems), by Product & Services (Reagents, Expression Vectors,
Competent Cells, Services, Instruments), by Application (Therapeutic, Industrial,
Research), by End User (Pharmaceutical and Biotechnology Companies, Academic
Research Institutes, Contract Research Organizations), by Geography (US, Canada, UK,
Germany, France, Italy, Spain, China, India, Japan, Brazil, Mexico, South Africa) - Global
Market Size, Share, Development, Growth and Demand Forecast, 2013-2023” at:
Protein Expression Market
Global protein expression market was worth
$1,400.4 million in 2016
According to the study, the global protein expression market is likely to
grow from $1.4 billion in 2016 to $3.0 billion by 2023. Major key players in
the market are developing products with technically advanced features that
are designed to produce high protein yield, maintaining a balance of speed
and scalability, thereby enhancing its application in the drug development
Some of the recent advanced product launched by the major players in the
market include Gibco ExpiCHO expression system, launched in 2015 by
ThermFisher Scientific Inc., that offers an increase yield of over 100-fold,
thereby enabling upto 3g/L of protein yield; in comparison to its previous
CHO system. Therefore, technically advanced products are a major factor
driving the growth of the market during the forecast period.
Protein Expression Market
Insights on market segments
As per the findings of the research, prokaryotic expression system occupied
the largest share of the protein expression market in 2016, due to the high
use of prokaryotic protein expression systems, since they are cheaper as
compared to other expression systems.
Based on products and services, reagents are expected to hold the largest
share of the protein expression market during the forecast period, mainly
attributable to increasing protein expression research activities and the
large-scale production of antibodies and vaccines.
Based on application, therapeutics held the largest share of the market in
2016, owing to the increasing prevalence of chronic diseases such as cancer
and diabetes around the world, and high efficacy of protein therapeutics.
Pharmaceutical & biotechnology companies were the largest end user of
the protein expression products in 2016, mainly due to the technological
advancement in protein expression research and rising production of
recombinant therapeutic proteins for disease treatment.
Protein Expression Market
North America stands as the largest protein
expression market
Geographically, North America has been the largest market for protein expression,
with the U.S. being the larger contributor to the regional market, as compared to
Canada. The dominant position of the North American market is mainly attributable
to the rise in R&D infrastructure, increased aging population, rise in healthcare
expenditure and increasing prevalence of chronic diseases in the region.
Europe is the second largest market for protein expression, after North America.
The Germany has been the largest contributor to the European protein expression
market, followed by the U.K. and France. The growth of the European market is
mainly attributable to the growing aging population, increase in infections, rising
incidences of cardiovascular diseases, chronic pain, and neurological disorders and
R&D infrastructure. The protein expression market is expected to witness the fastest
growth in Asia-Pacific during forecast period. Rising prevalence of diseases such as
cardiovascular disease and diabetes, increasing R&D spending, growing aging
population and increasing per capita income are some of the driving factors
boosting the Asia-Pacific market.
Protein Expression Market
Mergers and acquisitions: a key trend in the market
Increasing number of acquisitions is a key trend observed in the protein
expression market. The key players globally are acquiring segments and/or
companies to increase their share in the global market. In January 2017, BioRad Laboratories, Inc. (Bio-Rad) acquired RainDance Technologies, Inc.
(RainDance). As per the terms of acquisition, RainDance Technologies, Inc.
offered its droplet-based solutions to Bio-Rad Laboratories, Inc. and has
extended its reach into next generation sequencing applications. Similarly,
Takara Bio USA Holdings, Inc. (“TBUSH”) acquired Rubicon Genomics, Inc.
(Rubicon) in January 2017, the acquisition was aimed at expanding the product
portfolio in next generation sequencing sample preparation. TBUSH also
completed its acquisition of WaferGen Bio-systems, Inc. (WaferGen) in March
Protein Expression Market
Key players in the market are launching new products
to offer advanced protein expression products
Key players are launching new products in the market to offer advanced protein expression
products. In August 2017, Thermo Fisher Scientific Inc. launched Thermo Scientific Krios G3i
which is designed to deliver innovative enhancements necessary for rapid adoption of cryoEM. The Thermo Scientific Krios G3i can be used independently or together in a single particle
analysis workflow to make structural analysis of the proteins, protein complexes and other
biomolecular structures faster, easier and more accessible.
In July 2017, Agilent Technologies Inc. expanded its portfolio of instruments for molecular
diagnostics with the introduction of the AriaDx Real-Time PCR System. Real-time polymerase
chain reaction (PCR) is routinely used in laboratories to help identify pathogens, genotype
infectious agents, and for cancer diagnostics. The open platform of AriaDx makes it compatible
to existing fast chemistry-based assays that are DNA binding and probe-based. This feature
enables assay developers and partners with optimized reaction chemistries to quickly validate
their assays on the AriaDx.
Some of the other key players operating in this industry include Merck KGaA, Genscript
Biotech Corporation, Agilent Technologies, Inc., Promega Corporation, Bio-Rad Laboratories,
Inc., Qiagen N.V., New England Biolabs Inc., and Lonza Group Ltd.
Protein Expression Market
Download report sample at:
For information regarding permissions and other queries
Kindly write to:
[email protected]
US/Canada Toll-Free: 1-888-778-7886